The US Food and Drug Administration (FDA) have recorded another breakthrough in the treatment OF Acquired Immune Deficiency Syndrome (AIDS) with the discovery of a latest oral botanical drug, Crofelemer.
 |
| Maurice Iwu |
The latest breakthrough owes its success to a pioneering research carried out in the United States by a team of scientists which included Nigeria’s Maurice Iwu, an acclaimed pharmacologist and tropical medicine expert who carried out the research in the United States.
The latest invented drug is the second botanical, and an orally administered drug to be approved by FDA. It would be recalled that the first botanical drug to be approved in the United States was a topical green tea extract, Veregen, in 2006.
The latest invented drug is the second botanical, and an orally administered drug to be approved by FDA. It would be recalled that the first botanical drug to be approved in the United States was a topical green tea extract, Veregen, in 2006.
However, the drug, Crofelemer is the first to be approved in the United States to treat HIV -associated diarrhea. Crofelemer was from the latex of the South American sangre de drago tree (dragon’s blood, Croton lechleri). A red, blood-resembling latex leaks from the tree when its bark is cut, and it is this substance that contains the novel polymolecular structure crofelemer, originally developed and standardized by Shaman Pharmaceuticals.
Fulyzag is the second botanical drug approved by the agency. The drug’s approval marks an important event in the decades-long history of crofelemer.’’ Both botanical drugs meet all US pharmaceutical requirements and can be dispensed only by prescription.
Fulyzag is the second botanical drug approved by the agency. The drug’s approval marks an important event in the decades-long history of crofelemer.’’ Both botanical drugs meet all US pharmaceutical requirements and can be dispensed only by prescription.
Credit: Daily Post
No comments:
Post a Comment